The present invention relates to a pharmaceutical composition comprising an indirubin derivative as an effective ingredient for prevention or treatment of acute myeloid leukemia or metastatic breast cancer. When used, the composition of the present invention can effectively inhibit the activity of FLT3 kinase and can be usefully applied to the prevention or treatment of acute myeloid leukemia or metastatic breast cancer.